StockData

BGM Group Ltd. (BGM) stock

BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jul 21, 2026Score 9/30
$8.13+0.12 (+1.50%)

Close on Nov 17, 2026Market cap $3.26BP/E –Yield –

BGM cash

Cash and short-term investments held at the end of each period.

BGM's cash was $9.82M at Sep 30, 2025. For fiscal 2025 it was $9.82M, up 0.0% from the year before. The highest annual figure on record is $14.98M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Sep 30, 2025$9.82M+0.0%
FY2024Sep 30, 2024$9.82M+15.8%
FY2023Sep 30, 2023$8.48M-43.4%
FY2022Sep 30, 2022$14.98M+18.8%
FY2021Sep 30, 2021$12.61M+6.2%
FY2020Sep 30, 2020$11.87M+158.3%
FY2019Sep 30, 2019$4.59M-18.3%
FY2018Sep 30, 2018$5.62M-4.2%
FY2017Sep 30, 2017$5.87M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2025CQ3 2025Sep 30, 2025$9.82M+15.8%
Q2 FY2025CQ1 2025Mar 31, 2025$9.65M-0.6%
Q4 FY2024CQ3 2024Sep 30, 2024$9.82M-34.5%
Q2 FY2024CQ1 2024Mar 31, 2024$10.35M-37.9%
Q4 FY2023CQ3 2023Sep 30, 2023$8.48M-32.8%
Q2 FY2023CQ1 2023Mar 31, 2023$9.71M-18.1%
Q4 FY2022CQ3 2022Sep 30, 2022$14.98M+226.0%
Q2 FY2022CQ1 2022Mar 31, 2022$16.67M+196.3%
Q4 FY2021CQ3 2021Sep 30, 2021$12.61M+114.7%
Q4 FY2020CQ3 2020Sep 30, 2020$11.87M–
Q4 FY2019CQ3 2019Sep 30, 2019$4.59M–
Q4 FY2018CQ3 2018Sep 30, 2018$5.62M–
Q4 FY2017CQ3 2017Sep 30, 2017$5.87M–

More BGM figures

See a number that looks wrong?